Compare VTOL & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTOL | BLFS |
|---|---|---|
| Founded | 1948 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2011 | 2013 |
| Metric | VTOL | BLFS |
|---|---|---|
| Price | $40.92 | $25.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $58.00 | $32.00 |
| AVG Volume (30 Days) | 222.7K | ★ 710.3K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.02% | N/A |
| EPS Growth | 34.58 | ★ 77.27 |
| EPS | ★ 0.44 | 0.02 |
| Revenue | ★ $1,490,512,000.00 | $96,214,000.00 |
| Revenue This Year | $11.64 | $19.73 |
| Revenue Next Year | $5.59 | $17.82 |
| P/E Ratio | ★ $96.91 | $1,239.50 |
| Revenue Growth | 5.30 | ★ 16.97 |
| 52 Week Low | $32.43 | $17.86 |
| 52 Week High | $50.38 | $29.57 |
| Indicator | VTOL | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 36.83 | 50.43 |
| Support Level | $40.69 | $23.60 |
| Resistance Level | $42.44 | $26.41 |
| Average True Range (ATR) | 1.25 | 1.25 |
| MACD | 0.02 | -0.37 |
| Stochastic Oscillator | 5.76 | 12.41 |
Bristow Group Inc is the provider of vertical flight solutions. The group provides aviation services to a broad base of offshore energy companies and government entities. Its business comprises three reportable segments: Offshore Energy Services, Government Services, and Other Services. Its customers are in the UK, Norway, the USA, Nigeria, and Others. The offshore energy customers use services to transport personnel to, from and between offshore energy installations. The majority of revenue is generated from Offshore Energy Services.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.